These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12476071)

  • 1. Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile x males and females assessed by robust pedigree analysis.
    Loesch DZ; Huggins RM; Bui QM; Epstein JL; Taylor AK; Hagerman RJ
    J Dev Behav Pediatr; 2002 Dec; 23(6):416-23. PubMed ID: 12476071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis.
    Loesch DZ; Huggins RM; Bui QM; Taylor AK; Pratt C; Epstein J; Hagerman RJ
    Am J Med Genet A; 2003 Sep; 122A(1):13-23. PubMed ID: 12949966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variation and FMRP levels in fragile X.
    Loesch DZ; Huggins RM; Hagerman RJ
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):31-41. PubMed ID: 14994286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: a new perspective.
    Loesch DZ; Huggins RM; Bui QM; Taylor AK; Hagerman RJ
    Am J Med Genet A; 2003 Apr; 118A(2):127-34. PubMed ID: 12655493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X.
    Loesch DZ; Bui QM; Grigsby J; Butler E; Epstein J; Huggins RM; Taylor AK; Hagerman RJ
    Neuropsychology; 2003 Oct; 17(4):646-657. PubMed ID: 14599277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FMRP expression as a potential prognostic indicator in fragile X syndrome.
    Tassone F; Hagerman RJ; Iklé DN; Dyer PN; Lampe M; Willemsen R; Oostra BA; Taylor AK
    Am J Med Genet; 1999 May; 84(3):250-61. PubMed ID: 10331602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that fragile X mental retardation protein is a negative regulator of translation.
    Laggerbauer B; Ostareck D; Keidel EM; Ostareck-Lederer A; Fischer U
    Hum Mol Genet; 2001 Feb; 10(4):329-38. PubMed ID: 11157796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome.
    Kaufmann WE; Abrams MT; Chen W; Reiss AL
    Am J Med Genet; 1999 Apr; 83(4):286-95. PubMed ID: 10208163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of robust pedigree analysis in studies of complex genotype-phenotype relationships in fragile X syndrome.
    Loesch DZ; Huggins RM; Taylor AK
    Am J Med Genet; 2002 Jan; 107(2):136-42. PubMed ID: 11807888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMR1 gene and fragile X syndrome.
    Bardoni B; Mandel JL; Fisch GS
    Am J Med Genet; 2000; 97(2):153-63. PubMed ID: 11180223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes.
    Bardoni B; Mandel JL
    Curr Opin Genet Dev; 2002 Jun; 12(3):284-93. PubMed ID: 12076671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twin sisters, monozygotic with the fragile X mutation, but with a different phenotype.
    Willemsen R; Olmer R; De Diego Otero Y; Oostra BA
    J Med Genet; 2000 Aug; 37(8):603-4. PubMed ID: 10922388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X syndrome (review).
    Pimentel MM
    Int J Mol Med; 1999 Jun; 3(6):639-45. PubMed ID: 10341296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
    Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
    Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A profile of cognitive deficit in females from fragile X families.
    Miezejeski CM; Jenkins EC; Hill AL; Wisniewski K; French JH; Brown WT
    Neuropsychologia; 1986; 24(3):405-9. PubMed ID: 3736823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.
    Kenneson A; Zhang F; Hagedorn CH; Warren ST
    Hum Mol Genet; 2001 Jul; 10(14):1449-54. PubMed ID: 11448936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional neuroanatomy of visuospatial working memory in fragile X syndrome: relation to behavioral and molecular measures.
    Kwon H; Menon V; Eliez S; Warsofsky IS; White CD; Dyer-Friedman J; Taylor AK; Glover GH; Reiss AL
    Am J Psychiatry; 2001 Jul; 158(7):1040-51. PubMed ID: 11431225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion.
    Milà M; Castellví-Bel S; Giné R; Vazquez C; Badenas C; Sánchez A; Estivill X
    Hum Genet; 1996 Oct; 98(4):419-21. PubMed ID: 8792815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathogenesis of fragile X syndrome].
    Sielska D; Milewski M; Bal J
    Med Wieku Rozwoj; 2002; 6(4):295-308. PubMed ID: 12810982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.